Metrika

  • citati u SCIndeksu: 0
  • citati u CrossRef-u:0
  • citati u Google Scholaru:[]
  • posete u poslednjih 30 dana:4
  • preuzimanja u poslednjih 30 dana:4

Sadržaj

članak: 2 od 5  
Back povratak na rezultate
2018, vol. 52, br. 4, str. 134-139
Procena istorije skrininga papa testa kod pacijenata sa karcinomom grlića materice u provinciji Isfahan tokom 2014-2016 godine
Isfahan University of Medical Sciences, School of Medicine, Community Medicine Department, Isfahan, Iran

e-adresanegahtavakolifard@yahoo.com
Sažetak
Uvod. Odsustvo redovnog skrininga karcinoma grlića materice u Iranu i visoke stope dijagnostikovanog karcinoma u uznapredovalim stadijumima pokazuju važnost izvođenja skrininga. Stoga je cilj ove studije bio da se proceni istorija skrininga Papa testa kod pacijenata sa karcinomom grlića materice u provinciji Isfahan tokom 2014-2016 godine. Metode. U ovoj deskriptivno-analitičkoj studiji, 77 pacijenata sa karcinomom grlića materice je izabrano u provinciji Isfahan. Podaci su izdvojeni iz medicinske dokumentacije. Za analizu podataka korišćeni su Kruskal-Wallisov test, jednosmerna analiza, Chi-Square, Mann-Whithney, T test i Pearsonov test. Rezultati. U trenutnoj studiji, 38,9% pacijenata sa karcinomom grlića materice nije obavilo Papa test tokom svog života. Štaviše, 38.09% je obavilo skrining u period koji je kraći od 3 godine od postavljanja dijagnoze a 19.48% u period dužem od 3 godine. Postojala je značajna relacija između skrininga i starosti pri dijagnozi, broja trudnoća i starosti u trenutku prvog seksualnog odnosa (p<0,01). Statistička analiza je pokazala da je nivo obrazovanja bio veći kod pacijenata kod kojih je postavljena dijagnoza u period kraćem od 3 godine nego kod onih sa dijagnozom u period dužem od 3 godine (p=0,04). Učestalost pacijenata koji su vršili skrining u gradskoj zoni bila je značajno veća od ruralne (p= 0,048). Štaviše, uočena je značajna razlika između vrste provajdera usluga skrininga u smislu lokacije (p= 0,03). Zaključak. Rezultat ove studije ukazuje na ulogu uticajnih faktora na Papa test skriningu. Štaviše, istorija nečinjenja Papa testa u našoj zemlji u odnosu na druge zemlje je visoka što dovodi do odložene dijagnoze. Stoga je neophodan opšti program skrininga za poboljšanje svesti stanovništva u tom pogledu.
Reference
Allgar, V.L., Neal, R.D. (2005) Delays in the diagnosis of six cancers: analysis of data from the National Survey of NHS Patients: Cancer. British Journal of Cancer, 92(11): 1959-1970
Behnamfar, F., Azadehrah, M. (2015) Factors Associated with Delayed Diagnosis of Cervical Cancer in Iran - a Survey in Isfahan City. Asian Pacific Journal of Cancer Prevention, 16(2): 635-639
Bishwajit, G., Kpoghomou, M. (2017) Urban-rural differentials in the uptake of mammography and cervical cancer screening in Kenya. Journal of Cancer Policy, 12:43-48
Chen, C.S., Park, S., Shin, J.H., Nouri, Y., Kim, J., Yoon, H., Ko, G. (2018) Endovascular treatment for the control of active vaginal bleeding from uterine cervical cancer treated with radiotherapy. Acta Radiologica, 59(11): 1336-1342
Darlin, L., Borgfeldt, C., Widén, E., Kannisto, P. (2014) Elderly women above screening age diagnosed with cervical cancer have a worse prognosis. Anticancer Res, 34: 5147-51
Devi, B., Tang, T., Corbex, M. (2007) Reducing by half the percentage of late-stage presentation for breast and cervix cancer over 4 years: a pilot study of clinical downstaging in Sarawak, Malaysia. Annals of Oncology, 18(7): 1172-1176
Eleje, G.U., Eke, A.C., Igberase, G.O., Igwegbe, A.O., Eleje, L.I. (2016) Palliative interventions for controlling vaginal bleeding in advanced cervical cancer. John Wiley & Sons
Horner-Johnson, W., Dobbertin, K., Iezzoni, L.I. (2015) Disparities in Receipt of Breast and Cervical Cancer Screening for Rural Women Age 18 to 64 with Disabilities. Women's Health Issues, 25(3): 246-253
Jemal, A., Bray, F., Center, M.M., Ferlay, J., Ward, E., Forman, D. (2011) Global cancer statistics. CA: A Cancer Journal for Clinicians, 61(2): 69-90
Khorasanizadeh, F., Hassanloo, J., Khaksar, N., Mohammad, T.S., Marzaban, M., Rashidi, B., Akbari, S.A., Zendehdel, K. (2013) Epidemiology of cervical cancer and human papilloma virus infection among Iranian women - Analyses of national data and systematic review of the literature. Gynecologic Oncology, 128(2): 277-281
Louie, K. S., Castellsague, X., de Sanjose, S., Herrero, R., Meijer, C. J., Shah, K., Munoz, N., Bosch, F. X. (2011) Smoking and Passive Smoking in Cervical Cancer Risk: Pooled Analysis of Couples from the IARC Multicentric Case-Control Studies. Cancer Epidemiology Biomarkers & Prevention, 20(7): 1379-1390
Ma, J., Zhu, Q., Han, S., Zhang, Y., Ou, W., Wang, H., Zhao, J., Liu, Z. (2012) Effect of socio-economic factors on delayed access to health care among Chinese cervical cancer patients with late rectal complications after radiotherapy. Gynecologic Oncology, 124(3): 395-398
Massomi, Z., Khani, S., Gharosian, M., Farhadian, M., Shayan, A. (2016) The prevalence of abnormal Pap smears in females referred to health centers affiliated to medical sciences during the Years 2012 to 2016. J Educ Community Health, 3: 16-22
Nygård, J.F., Skare, G.B., Thoresen, S.Ø. (2002) The cervical cancer screening programme in Norway, 1992-2000: changes in Pap smear coverage and incidence of cervical cancer. Journal of Medical Screening, 9(2): 86-91
Orwat, J., Caputo, N., Key, W., de Sa, J. (2017) Comparing Rural and Urban Cervical and Breast Cancer Screening Rates in a Privately Insured Population. Social Work in Public Health, 32(5): 311-323
Othman, N.H., Devi, B.C., Halimah, Y. (2009) Cervical cancer screening: patients understanding in major hospitals in Malaysia. Asian Pacific J Cancer Prev, 10: 569-74
Samet, J.M., Yoon, S.Y. (2010) Gender, women, and the tobacco epidemic. Geneva: World Health Organization
Shy, K., Chu, J., Mandelson, M., Greer, B., Figge, D. (1989) Papanicolaou smear screening interval and risk of cervical cancer. Obstet Gynecol, 74: 838-43
Spence, A.R., Alobaid, A., Drouin, P., Goggin, P., Gilbert, L., Provencher, D., Tousignant, P., Hanley, J.A., Franco, E.L. (2014) Screening histories and contact with physicians as determinants of cervical cancer risk in Montreal, Quebec. Current Oncology, 21(6): 294
Subramaniam, A., Fauci, J.M., Schneider, K.E., Whitworth, J.M., Erickson, B.K., Kim, K., Huh, W.K. (2011) Invasive Cervical Cancer and Screening. Journal of Lower Genital Tract Disease, 15(2): 110-113
Thomson, C.S., Forman, D. (2009) Cancer survival in England and the influence of early diagnosis: what can we learn from recent EUROCARE results?. British Journal of Cancer, 101(S2): S102-S109
Vinh-Hung, V., Bourgain, C., Vlastos, G., Cserni, G., de Ridder, M., Storme, G., Vlastos, A. (2007) Prognostic value of histopathology and trends in cervical cancer: a SEER population study. BMC Cancer, 7(1)
WHO International Agency for Research on Cancer (IARC) (2004) Tobacco smoke and involuntary smoking. Lyon, France